David Krempa, Chief Business Officer at Eton Pharmaceuticals ($ETON), made three open market sales of company shares over the past year, totaling about half a million dollars. His most recent sale occurred on June 16, 2025. These transactions rank 6416th among 11,678 insiders in our database, well below the average sale amount of $8.6 million across roughly 6.4 transactions per insider. Krempa reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 14, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | F | Common Stock | 1942 | $15.62 | 630,238.0000 | 26,893,000 | 0.31% | 0.01% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Restricted Stock Units | 25856 | $0.00 | 696,749.0000 | 26,893,000 | 3.85% | 0.10% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 40655 | $0.00 | 670,893.0000 | 26,893,000 | 6.45% | 0.15% |
| Dec. 11, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Restricted Stock Units | 5300 | $0.00 | 638,468.0000 | 26,893,000 | 0.84% | 0.02% |
| Dec. 12, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | F | Common Stock | 6264 | $17.00 | 632,180.0000 | 26,893,000 | 0.98% | 0.02% |
| June 12, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | S | Common Stock | 16977 | $14.92 | 629,669.0000 | 25,895,086 | 2.63% | 0.07% |
| June 13, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | S | Common Stock | 6800 | $14.77 | 622,869.0000 | 25,895,086 | 1.08% | 0.03% |
| June 16, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | S | Common Stock | 10223 | $14.73 | 612,646.0000 | 25,895,086 | 1.64% | 0.04% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Restricted Stock Units | 25876 | $0.00 | 25,876.0000 | 25,895,086 | 9999.99% | 0.10% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 38621 | $0.00 | 38,621.0000 | 25,895,086 | 9999.99% | 0.15% |
| Oct. 2, 2024 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Restricted Stock Units | 42088 | $0.00 | 861,374.0000 | 25,900,000 | 5.14% | 0.16% |
| Feb. 13, 2024 | Eton Pharmaceuticals, Inc. | $ETON | Krempa David | Chief Business Officer | A | Stock Option (Right to buy) | 144677 | $0.00 | 813,430.0000 | 25,645,366 | 21.63% | 0.56% |